Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513162-20-000040
Filing Date
2020-03-09
Accepted
2020-03-09 17:10:56
Documents
65
Period of Report
2020-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 894512
2 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 12574
3 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 13322
4 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 7113
5 EXHIBIT 32.2 exhibit32_2.htm EX-32.2 7900
  Complete submission text file 0001513162-20-000040.txt   4671859

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT anix-20200131.xml EX-101.INS 1068613
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anix-20200131.xsd EX-101.SCH 53180
8 XBRL TAXONOMY EXTENSION CALCULATIONS LINKBASE DOCUMENT anix-20200131_cal.xml EX-101.CAL 29025
9 XBRL TAXONOMY EXTENSION DEFINTIONS LINKBASE DOCUMENT anix-20200131_def.xml EX-101.DEF 256164
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT anix-20200131_lab.xml EX-101.LAB 322437
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anix-20200131_pre.xml EX-101.PRE 245765
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-37492 | Film No.: 20698795
SIC: 8071 Services-Medical Laboratories